Mets Acquire Francisco Lindor, Carlos Carrasco in Blockbuster Trade

The blockbuster trade New York Mets fans have been waiting for has been finalized, as the team officially reported Francsico Lindor and Carlos Carrasco are heading to Queens.

The deal will send shortstops Amed Rosario and Andrés Giménez, RHP Josh Wolf (second-round pick in 2019), and OF Isaiah Greene (second-round compensation pick and the Mets’ No. 10 prospect) to the Cleveland Indians.

It was believed shortstop Lindor, 27, would be dealt this offseason as he was in line to be a free agent after this season. Now, the four-time All-Star who has received MVP votes in every season from 2016-2019 will join the Mets as the first major move with Steve Cohen at the helm.

During his six-year stint with the Indians, Lindor had a .285 batting average, .346 OPS, .488 SLG, and .833 OPS. He has crushed 138 home runs and recorded 411 RBI. His WAR is 28.7.

Lindor is a two-time Gold Glove award winner (2016, 2019), won the AL Platinum Glove for the best overall defender in 2016, and is a two-time Silver Slugger (2017, 2018). He ranks third in MLB with 258 extra-base hits since 2017 and ranks third in runs scored (359), fifth in hits (592), tied for 12th in home runs (111), and 17th in stolen bases with 68, per the Mets.

RHP Carrasco, 33, is coming off a 3-4 season in 2020 with a 2.91 ERA over 12 games. In his 11 years with the Indians, he has notched a 3.77 ERA with an 88-73 record over 242 games. Carrasco has recorded 321 walks and 1,305 strikeouts over his MLB career.

Named the AL Comeback Player of the Year after being diagnosed with leukemia in 2019, Carrasco was seventh in the AL with a 2.91 ERA over 12 starts in 2020 and was sixth with 82 strikeouts in 68 innings. He is tied for 10th in MLB with 69 wins, 11th in strikeouts with 1,001, and 15th in ERA (3.54) since 2015, per the Mets.

The additions are a sign Steve Cohen is prepared to continue to bolster the Mets’ lineup and defense, along with the starting rotation.

(Photo: AP Photo/Paul Sancya)

Leave a Reply

0